Tuesday, March 15, 2016

Spirox Gets $45M For Medical Device

Menlo Park-based Spirox, which is developing medical devices for treating nasal obstruction, has raised $45M in a Series C funding. The funding was led by KKR, and also included HealthQuest Capital, Aisling Capital, Aperture Venture Partners and Venrock. Spirox is develping a minimally invasive system with nasal obstruction, which it sells to Ear, Nose and Throat (ENT) physicians and plastic surgeons. More information »